Norgestimate 0.18mg, ethinyl estradiol 35mcg (7 tabs); norgestimate 0.215mg, ethinyl estradiol 35mcg (7 tabs); norgestimate 0.25mg, ethinyl estradiol 35mcg (7 tabs); inert (7 tabs). High risk of ...
Norgestimate 0.18mg, ethinyl estradiol 35mcg (7 tabs); norgestimate 0.215mg, ethinyl estradiol 35mcg (7 tabs); norgestimate 0.25mg, ethinyl estradiol 35mcg (7 tabs); inert (7 tabs). High risk of ...
Hepatic vein thrombosis is caused by one or several thrombogenic conditions, of which myeloproliferative disorders are the most frequent. Thrombosis and its fibrous sequelae can affect the veins ...
It is a low-profile non thrombogenic system that shields all cerebral vessels, delivered through the left radial artery for optimal placement and stability. This is an ideal access site enabling ...
Wolfe PS, Madurantakam P, Garg K, Sell SA, Beckman MJ, Bowlin GL (2009), Evaluation of Thrombogenic Potential of Electrospun Bioresorbable Vascular Graft Materials: Acute Monocyte Tissue Factor ...
The underlying conditions favoring or precipitating hepatic vein or inferior vena cava thrombosis must be recognized and treated. This essential part of therapy is beyond the scope of this review ...
It is a low-profile non thrombogenic system that shields all cerebral vessels, delivered through the left radial artery for optimal placement and stability. This is an ideal access site enabling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback